Interleukin-2 receptor β chain as a possible target for low doses of mafosfamide

The 7-day cytotoxic lymphocytes (CTL) induced in mixed lymphocyte culture express only the chain of the interleukin-2 receptor (IL-2R). In the present study this fact has been confirmed in a murine semi-allogeneic system. The ability of low doses of mafosfamide (Mf) to affect IL-2-induced CTL prolif...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Pukhalsky (Author), A. Toptygina (Author), S. Khaidukov (Author)
Format: Book
Published: Hindawi Limited, 1995-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_710b19d0edf94c3fab355b1e5a6c69b3
042 |a dc 
100 1 0 |a A. Pukhalsky  |e author 
700 1 0 |a A. Toptygina  |e author 
700 1 0 |a S. Khaidukov  |e author 
245 0 0 |a Interleukin-2 receptor β chain as a possible target for low doses of mafosfamide 
260 |b Hindawi Limited,   |c 1995-01-01T00:00:00Z. 
500 |a 0962-9351 
500 |a 1466-1861 
500 |a 10.1155/S0962935195000287 
520 |a The 7-day cytotoxic lymphocytes (CTL) induced in mixed lymphocyte culture express only the chain of the interleukin-2 receptor (IL-2R). In the present study this fact has been confirmed in a murine semi-allogeneic system. The ability of low doses of mafosfamide (Mf) to affect IL-2-induced CTL proliferation has been demonstrated. It was also shown that IL-2 activated resting suppressor cells. The pretreatment of the suppressor cells with either monoclonal antibodies (mAbs) against the p75 chain of IL-2R, or with Mf abolished the suppressive effect of these cells. No restoration of the proliferative response occurred when the anti-IL-2Rα mAb had been used. Flow cytometry analysis of 7-day CTL was carried out with mAbs against the α and β chains of IL-2R. CTL treatment with Mf inhibited anti-IL-2Rβ mAb binding. It may be assumed that the anti-proliferative effects of Mf which have been demonstrated in this paper, were a result of blocking the IL-2R β chain. 
546 |a EN 
690 |a Pathology 
690 |a RB1-214 
655 7 |a article  |2 local 
786 0 |n Mediators of Inflammation, Vol 4, Iss 3, Pp 175-180 (1995) 
787 0 |n http://dx.doi.org/10.1155/S0962935195000287 
787 0 |n https://doaj.org/toc/0962-9351 
787 0 |n https://doaj.org/toc/1466-1861 
856 4 1 |u https://doaj.org/article/710b19d0edf94c3fab355b1e5a6c69b3  |z Connect to this object online.